Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6814198
Reference Type
Journal Article
Subtype
Review
Title
Use of DNA methylation for cancer detection: Promises and challenges
Author(s)
Zhu, J; Yao, X
Year
2009
Is Peer Reviewed?
Yes
Journal
International Journal of Biochemistry and Cell Biology
ISSN:
1357-2725
Volume
41
Issue
1
Page Numbers
147-154
Language
English
PMID
18834953
DOI
10.1016/j.biocel.2008.09.003
Web of Science Id
WOS:000262620400020
Abstract
DNA methylation is an important and reversible epigenetic modification, which regulates genomic stability and cellular plasticity. Faithful DNA methylation is essential for mammalian development and health, and perturbation of methylation dynamics contributes to the development of disease, including cancer. The discovery and validation of the biological indicators (biomarkers) for human cancers are essential steps in the development of methods for accurate subtype classification and outcome prediction in clinic oncology. While genetics (SNP, LOH and mutation) and expression profiling (mRNA and protein) of biomarkers have been extensively assessed for cancer diagnosis and prognosis, the potential for using epigenetic fingerprints for early diagnosis and outcome prediction in clinic oncology propels the exploration of using DNA methylation as a biomarker for cancer prognosis. Both the promises and challenges to realizing the clinical utility of the DNA methylation in cancer management are discussed in this review.
Keywords
DNA methylation; Biomarker; Cancer; Diagnosis and epigenetics
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity